Mariner, LLC Biogen Inc. Transaction History

Mariner, LLC

$51.1 Billion
Q2 2024

A detailed history of Mariner, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Mariner, LLC holds 23,114 shares of BIIB stock, worth $4.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

23,114

Previous 21,076 9.67%

Holding current value

$4.02 Million

Previous $4.54 Million 17.91%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $388,279 - $482,435	2,038 Added 9.67%	23,114 $5.36 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $96,045 - $121,272	-453 Reduced 2.1%	21,076 $4.54 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $415,798 - $500,511	1,868 Added 9.5%	21,529 $5.57 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $71,430 - $80,620	-282 Reduced 1.41%	19,661 $5.05 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $528,755 - $610,993	1,921 Added 10.66%	19,943 $5.68 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $485,154 - $552,814	-1,891 Reduced 9.5%	18,022 $5.01 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $132,531 - $161,028	525 Added 2.71%	19,913 $5.51 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $909,396 - $1.25 Million	4,671 Added 31.74%	19,388 $5.18 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $45,947 - $54,639	245 Added 1.69%	14,717 $3 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $316,813 - $399,168	1,635 Added 12.74%	14,472 $3.05 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $155,848 - $200,287	-696 Reduced 5.14%	12,837 $3.08 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $586,921 - $765,409	2,074 Added 18.1%	13,533 $3.83 Million
Q2 2021 Aug 24, 2021	SELL	$259.0 - $414.71 $117,068 - $187,448	-452 Reduced 3.79%	11,459 $3.97 Million
Q1 2021 May 07, 2021	BUY	$242.95 - $284.63 $218,412 - $255,882	899 Added 8.16%	11,911 $3.33 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $2.6 Million - $3.92 Million	11,012 New	11,012 $2.7 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $2.74 Million - $3.07 Million	-12,597 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $190,563 - $210,054	869 Added 7.41%	12,597 $2.95 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $74,548 - $116,602	344 Added 3.02%	11,728 $2.77 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $2.3 Million - $2.91 Million	8,243 Added 262.43%	11,384 $3.43 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $146,167 - $191,147	498 Added 18.84%	3,141 $1.11 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $421,560 - $502,411	1,637 Added 162.72%	2,643 $767,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $261,690 - $370,117	1,006 New	1,006 $275,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account